Related Experiment Video
Updated: Aug 12, 2026

07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Transsphenoidal and transcranial surgery for pituitary adenomas
1Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, UT 84132-2303, USA. william.couldwell@hsc.utah.edu
Journal of Neuro-Oncology
|November 6, 2004
Summary
Pituitary surgery has advanced significantly over 100 years, with the transsphenoidal approach becoming standard for tumor removal. Techniques now include microscopic, endoscopic, and adjuvant stereotactic radiosurgery for complex cases.
Area of Science:
- Neurosurgery
- Endocrinology
- Surgical Oncology
Background:
- Pituitary surgery aims to remove tumors, preserve function, and correct hormonal imbalances.
- The transsphenoidal approach, pioneered over a century ago, is now the primary method for pituitary tumor resection.
Purpose of the Study:
- To review the historical development and advancements in pituitary surgery over the past century.
- To discuss contemporary surgical techniques, including microscopic and endoscopic approaches.
- To evaluate the role of stereotactic radiosurgery as an adjuvant therapy for complex pituitary adenomas.
Main Methods:
- Historical review of pituitary surgical techniques.
- Discussion of transsphenoidal, transcranial, microscopic, and endoscopic surgical approaches.
- Analysis of the integration of stereotactic radiosurgery (SRS) in pituitary tumor management.
Main Results:
- The transsphenoidal approach has evolved into the preferred method for most pituitary tumor surgeries.
- Microscopic and endoscopic techniques have refined tumor removal and functional preservation.
- Stereotactic radiosurgery is increasingly used for challenging adenomas, particularly those with cavernous sinus invasion.
Conclusions:
- Pituitary surgery has made substantial progress, enhancing tumor resection and patient outcomes.
- The evolution of transsphenoidal techniques, alongside adjuvant SRS, offers comprehensive management strategies for pituitary tumors.

